Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2509-2512

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edelman, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edelman, E. R.

(Circulation. 2001;104:2509.)
© 2001 American Heart Association, Inc.


Editorial

On Causes

Hippocrates, Aristotle, Robert Koch, and the Dread Pirate Roberts

Elazer R. Edelman, MD PhD

From the Harvard-MIT Division of Health Sciences and Technology and the Cardiovascular Division of Brigham and Women’s Hospital and Harvard Medical School, Cambridge, Mass.

Correspondence to Elazer R. Edelman, MD, PhD, Harvard-MIT Division of Health Sciences and Technology and the Cardiovascular Division of Brigham and Women’s Hospital and Harvard Medical School, MIT, 16-343, Cambridge, MA 02139. E-mail ere@mit.edu


Key Words: Editorials • risk factors • cardiovascular diseases

But let us inquire what are the causes of these things which happened to them.

— Hippocrates 1

The idea of risk factors for vascular disease has evolved from a dichotomous to continuous hazard analysis and from the consideration of a few factors to mechanistic investigation of many interrelated risks. However, confusion still abounds regarding issues of association and causation. Originally, the simple presence of tobacco abuse, hypertension, and/or hypercholesterolemia were tallied, and the cumulative score was predictive of subsequent coronary artery disease.2 Since then, dose responses have been defined for these and other factors and it has been suggested that almost 300 factors place patients at risk; these factors include elevations in plasma homocysteine. Recent studies shed interesting light on the mechanism of this potentially causal relationship, which was first noted in 1969.3 Aside from putative effects on vessel wall dynamics, there is now direct evidence that homocysteine is atherogenic. Twenty-fold increases in plasma homocysteine achieved by dietary manipulation of apoE–/– mice increased aortic root lesion size 2-fold and produced a prolonged chronic inflammatory mural response accompanied by elevations in vascular cell adhesion molecule-1 and tumor necrosis factor-{alpha}.4 In long term follow-up, homocysteine levels elevated by dietary supplementation with methionine or homocysteine promoted lesion size and plaque fibrosis in these atherosclerosis-prone mice early in life, but without influencing ultimate plaque burden as the animals aged.5 A number of mechanisms were proposed by which homocysteine achieved this effect, including promotion of inflammation, regulation of lipoprotein metabolism, and modification of . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Vasc MedHome page
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Vascular Medicine, August 1, 2002; 7(3): 213 - 225.
[Abstract] [PDF]